Conclusion: Tiaozhi Capsule can prolong APTT, PT, TT, and influence PAG, and improve the function of the platelet and prevent the formation of thrombus to cure the AS.
结论调脂胶囊可通过延长血浆中aptt、PT、TT，影响PAG，改善血小板的功能，防止血栓的形成，以发挥抗动脉粥样硬化的作用。
Objective To investigate the effects of different storage temperatures on anticoagulated blood hemagglutination tests, including prothrombin time(PT), and activated partial thromboplastin time(APTT).
目的探讨不同的抗凝血体外贮存条件对凝血酶原时间（PT）、活化部分凝血活酶时间（APTT）的影响。
Objective: To explore clinical significance of detecting prothrombin time (PT), the activated partial thromboplastin time (APTT), thrombin time (TT), plasma fibrinogen (fib) for parturient women.
目的：探讨检测临产孕妇凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、纤维蛋白原(FIB)的临床意义。
Results The PT, APTT, TT and D-D obviously prolong but the FIB obviously descend, those patients indices showed the significant difference in compared with normal control subjects(P<0.01).
结果肝硬化患者与对照组比较PT、APTT、TT及D-D均明显延长而FIB则明显下降，两者比较差异有显著性（P<0.01）。
The blood coagulative system in three groups was evaluated by testing platelet count (PLC), Active part thrombin time (APTT), prothrombin time (PT), thrombin time (TT), FIBrinogen(FIB).
血小板计数（PLC） ，活化部分凝血活酶时间（APTT）、凝血酶原时间（PT）、凝血酶时间（TT）和纤维蛋白原定量（FIB）。
Plasma prothrombin time (PT), activate part plasma prothrombin time (APTT), prothrombin time (TT) , fibrinogen (FIB) the level of fasting blood glucose (GLU) are tested separately.
分别测定血浆凝血酶原时间（PT）、活化部分凝血酶原时间（APTT）、凝血酶时间（TT），纤维蛋白原（FIB）、血清空腹血糖（GLU）水平。
The prothrombin time(PT) and the active partial thromboplastin time(APTT) were measured by the ACL- 200 antomatic blood agglutination instrument.
用ACL-200型血液凝集仪测定大鼠凝血酶原时间（PT）和部分凝血活酶时间（APTT）。
Objective To study the clinical value of detecting several common cancer patients' protothrombin time(PT), thrombin time (TT), active part thrombin time(APTT) and fibrinogen(FIB).
目的研究几种常见的癌症患者血浆凝血酶原时间（PT）、凝血酶时间（TT）、活化部分凝血酶时间（APTT）、纤维蛋白原（FIB）测定的临床价值。
Objective To explore the changes of plasma levels of PT, APTT, fibrinogen in pregnancy complicating with hypertension and its clinical significance.
目的探讨妊娠期高血压疾病妇女血浆凝血因子的变化及临床意义。
Results: PT and APTT in the patients with fracture were significantly more increased than those in controls, and were not corrected by normal fresh plasma.
结果：患病组的PT和APTT较正常对照组有显著延长，且不能被正常新鲜血浆纠正。
The results showed that PT and APTT were prolonged by exogenous TFPI.
结果发现：外源性的组织因子途径抑制物(TFPI)可使PT及APTT延长。
The regular heparin group showed significant difference in the level of PT and APTT compared with the N-desulfated heparin group(P<0.05).
脱硫酸肝素组与普通肝素组在PT、APTT方面均存在显著性差异（P<0.05）。
Conclusion the measures of FBG, D-dimer, HCT, BV, PV and PT, APTT, TT in CPHDA may provide some indication of the disease severity and the prognosis.
结论血浆D -二聚体，FBG，血液流变学，凝血功能监测对评估疾病程度及其预后以及疗效观察提供有力的依据。
The anticoagulant test results show that the APTT, PT, TT of modification PVC films increase obviously. As a result, the blood compatibility of PVC films is improved greatly.
抗凝血性能测试结果表明，改性后薄膜的凝血因子APTT、PT、TT时间显著提高，血液相容性得到了明显的提高。
PT and APTT did not change in hemofiltration without anticoagulation (P>0.05), while APTT was prolonged in hemofiltration with heparin (P<0.01).
肝素抗凝血液滤过治疗后APTT明显延长（P<0.01），而PT未产生明显改变（P>0.05）。
The index of coagulation PLT, FIB increased more than the control group, and APTT, PT drop by more than the control group, the difference was statistically significant (P<0.05).
治疗组的血小板、纤维蛋白原计数较对照组明显升高，PT、APTT较对照组明显下降，具有显著性差异（P<0.05）。
Results PLT, PT, APTT were significantly shorter and FIB was higher in pregnancy complicating with hypertension than in later terms pregnancy women and non-pregnancy women(P<0.05);
结果妊娠期高血压疾病组妇女的PLT、PT、APTT测定值明显低于正常妊娠晚期妇女和非妊娠妇女（P<0.05）；
Methods:The results of PT, APTT, TT , FIB for 3042 parturient women and 396 normal women were compared.
方法：对3 042例临产孕妇（实验组）与396例正常非妊娠妇女（对照组）的凝血四项指标进行比较分析。
Methods:The results of PT, APTT, TT , FIB for 3042 parturient women and 396 normal women were compared.
方法：对3 042例临产孕妇（实验组）与396例正常非妊娠妇女（对照组）的凝血四项指标进行比较分析。
应用推荐